ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Study of MK2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (2206-003 AM5)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00848718
Recruitment Status : Completed
First Posted : February 20, 2009
Last Update Posted : January 22, 2015
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.